Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction
This study has been terminated.
( Enrollment discontinued after second cohort completed. )
Study NCT00550849   Information provided by Reata Pharmaceuticals, Inc.

First Received on October 26, 2007.   Last Updated on November 6, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Liver Disease
Additional conditions recognized in this trial
Liver Diseases
More general conditions related to this trial
Digestive System Diseases
Interventions listed in this trial
RTA 402
Sponsors listed in this trial
Reata Pharmaceuticals, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services